AU505075B2 – Foetal canine lung cell strain and process for cultivation of viruses and vaccine therefrom
– Google Patents
AU505075B2 – Foetal canine lung cell strain and process for cultivation of viruses and vaccine therefrom
– Google Patents
Foetal canine lung cell strain and process for cultivation of viruses and vaccine therefrom
Info
Publication number
AU505075B2
AU505075B2
AU13865/76A
AU1386576A
AU505075B2
AU 505075 B2
AU505075 B2
AU 505075B2
AU 13865/76 A
AU13865/76 A
AU 13865/76A
AU 1386576 A
AU1386576 A
AU 1386576A
AU 505075 B2
AU505075 B2
AU 505075B2
Authority
AU
Australia
Prior art keywords
foetal
viruses
cultivation
cell strain
lung cell
Prior art date
1975-05-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU13865/76A
Other versions
AU1386576A
(en
Inventor
V. J Cabasso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Cutter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1975-05-12
Filing date
1976-05-12
Publication date
1979-11-08
1976-05-12
Application filed by Cutter Laboratories Inc
filed
Critical
Cutter Laboratories Inc
1977-11-17
Publication of AU1386576A
publication
Critical
patent/AU1386576A/en
1979-11-08
Application granted
granted
Critical
1979-11-08
Publication of AU505075B2
publication
Critical
patent/AU505075B2/en
Status
Expired
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
A61K39/12—Viral antigens
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
C12N2710/00011—Details
C12N2710/16011—Herpesviridae
C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
C12N2710/00011—Details
C12N2710/16011—Herpesviridae
C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
C12N2710/16751—Methods of production or purification of viral material
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
C12N2720/00011—Details
C12N2720/12011—Reoviridae
C12N2720/12111—Orbivirus, e.g. bluetongue virus
C12N2720/12134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
C12N2720/00011—Details
C12N2720/12011—Reoviridae
C12N2720/12111—Orbivirus, e.g. bluetongue virus
C12N2720/12151—Methods of production or purification of viral material
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
C12N2760/00011—Details
C12N2760/18011—Paramyxoviridae
C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
C12N2760/00011—Details
C12N2760/18011—Paramyxoviridae
C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
C12N2760/18451—Methods of production or purification of viral material
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
C12N2760/00011—Details
C12N2760/18011—Paramyxoviridae
C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
C12N2760/00011—Details
C12N2760/18011—Paramyxoviridae
C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
C12N2760/18651—Methods of production or purification of viral material
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
C12N2760/00011—Details
C12N2760/20011—Rhabdoviridae
C12N2760/20111—Lyssavirus, e.g. rabies virus
C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
C12N2760/00011—Details
C12N2760/20011—Rhabdoviridae
C12N2760/20111—Lyssavirus, e.g. rabies virus
C12N2760/20151—Methods of production or purification of viral material
AU13865/76A
1975-05-12
1976-05-12
Foetal canine lung cell strain and process for cultivation of viruses and vaccine therefrom
Expired
AU505075B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US57652775A
1975-05-12
1975-05-12
USUS576,527
1975-05-12
Publications (2)
Publication Number
Publication Date
AU1386576A
AU1386576A
(en)
1977-11-17
AU505075B2
true
AU505075B2
(en)
1979-11-08
Family
ID=24304804
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU13865/76A
Expired
AU505075B2
(en)
1975-05-12
1976-05-12
Foetal canine lung cell strain and process for cultivation of viruses and vaccine therefrom
Country Status (6)
Country
Link
AR
(1)
AR212170A1
(en)
AU
(1)
AU505075B2
(en)
CA
(1)
CA1064395A
(en)
ES
(1)
ES446396A1
(en)
GB
(1)
GB1501556A
(en)
NZ
(1)
NZ180813A
(en)
1976
1976-03-26
ES
ES446396A
patent/ES446396A1/en
not_active
Expired
1976-04-08
CA
CA249,860A
patent/CA1064395A/en
not_active
Expired
1976-04-09
GB
GB1463276A
patent/GB1501556A/en
not_active
Expired
1976-05-10
NZ
NZ18081376A
patent/NZ180813A/en
unknown
1976-05-12
AU
AU13865/76A
patent/AU505075B2/en
not_active
Expired
1976-05-12
AR
AR26325876A
patent/AR212170A1/en
active
Also Published As
Publication number
Publication date
GB1501556A
(en)
1978-02-15
ES446396A1
(en)
1977-10-16
AR212170A1
(en)
1978-05-31
NZ180813A
(en)
1979-03-16
AU1386576A
(en)
1977-11-17
CA1064395A
(en)
1979-10-16
Similar Documents
Publication
Publication Date
Title
RO76939A
(en)
1981-06-22
PROCESS FOR THE PREPARATION OF SUBSTITUTED SHEETS
HU175569B
(en)
1980-09-28
Insecticides and process for preparing benzoyi-ureido-diphenyl-ether derivatives used as active materials thereof
RO86176A
(en)
1985-03-15
PROCESS FOR THE PREPARATION OF 6-BETA-HYDRO-CYCLOPYLICANIC ACID ESTERS
JPS52114018A
(en)
1977-09-24
Purification and isolation of hepatisis virus for producing vaccine
AU532282B2
(en)
1983-09-22
Cultivation of marron
GR61175B
(en)
1978-10-03
Preparation process of (1-phenyl-2-triazolyl-ethyl)-ether-derivatives and use thereof as fungicides
DE2963201D1
(en)
1982-08-12
Purified bacterial proteoglycans, process for their preparation and vaccine containing them
RO69720A
(en)
1980-08-15
PROCESS FOR PREPARATION OF (- (PERFLUORACYL) -N-PHOSFONOMETIGLICINE
RO76811A
(en)
1981-05-30
PROCESS FOR THE PREPARATION OF OXIMINOTRIOZOLITANES
RO71908A
(en)
1981-11-24
PROCESS FOR PREPARATION OF 7-BETA-ACYLAMINO-3-CHLORO-3-CEFEM-4-CARBOXYLIC ACID ACID
AU535804B2
(en)
1984-04-05
Influenza vaccine production
JPS51133414A
(en)
1976-11-19
Production of vaccine against viral hepatisis
AU497678B2
(en)
1978-12-21
Preparation of polyamines
JPS5218814A
(en)
1977-02-12
Production of hydrophobia virus strain and hydrophobia vaccine containg same
AU505075B2
(en)
1979-11-08
Foetal canine lung cell strain and process for cultivation of viruses and vaccine therefrom
GB1554310A
(en)
1979-10-17
Process for the preparation of 5-oxo-hexanoic acid and derivatives thereof
GR61598B
(en)
1978-12-02
Disubstituted phenolethers of 3-amino-2-hydroxypropan,preparation process thereof and use thereof as medicines
PT65754A
(en)
1976-11-01
Process for preparing novel derivatives of aroyl-phenylindenes and aroyl-phenylnaphthalenes
IL51057A0
(en)
1977-02-28
Thiadiazolyl derivatives of 7-acylamido-3-cephem-4-carboxylic acid and process for their preparation
JPS5221315A
(en)
1977-02-17
Production of herpesvirus of cat * vaccine thereof and method of protecting cat from herpesvirus
JPS54113421A
(en)
1979-09-05
Large scale cultivation of virus
RO69114A
(en)
1980-08-15
PROCESS FOR PREPARATION OF 2-ACYLAMINOXACOLS
RO79220A
(en)
1982-06-25
PROCESS FOR THE PREPARATION OF ALCOXYCARBONYLAMINOPHENYL ESTERS OF CARBANYLIC ACID
EG12354A
(en)
1978-12-31
Process for preparing of novel substituted thionophosphonic acid dialkyl esters,and their use as insecticides
JPS52156920A
(en)
1977-12-27
Proauction of raw influenza virus vaccine
None